0.9232USD-5.40%Mkt Cap: 40.89M $P/E: —4d ago
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiov…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap40.89M $
Enterprise Value24.42M $
Revenue (TTM)12.14M $
Gross Profit6.60M $
Net Income (TTM)53.38M $
Revenue/Share0.2820 USD
Last Price0.9232 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.82
PEG—
EV/EBITDA-1.14
EV/Revenue2.01
P/S3.29
P/B2.53
EPS (TTM)-0.63
EPS (Forward)-1.10
52W Range
0.500021% of range2.500
52W High2.500 USD
52W Low0.5000 USD
Profitability
Gross Margin53.66%
Oper. Margin-243.10%
EBITDA Margin-175.95%
Profit Margin434.23%
ROE192.90%
ROA85.61%
Growth
Revenue Growth-11.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.81M $
CapEx (TTM)1.88M $
FCF Margin-226.38%
FCF Yield-67.19%
Net Debt-15.52M $
Net Debt/EBITDA0.73
Balance Sheet
Debt/Equity0.14
Current Ratio1.77
Quick Ratio1.01
Book Value/Sh0.3560 USD
Cash/Share0.4490 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.000 USD
Upside (mean)+441.6%
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.44.29M
Float29.50M
Insiders3.50%
Institutions43.82%
Short Interest
Short Ratio0.4d
Short % Float0.10%
Short % Out.0.09%
Shares Short39.66K
Short (prev mo.)52.92K
Technical
SMA 500.9332 (-1.1%)
SMA 2000.9382 (-1.6%)
Beta0.88
S&P 52W Chg18.16%
Avg Vol (30d)70.78K
Avg Vol (10d)52.72K
Technical Indicators
RSI (14)52.2
MACD-0.0117
MACD Signal-0.0247
MACD Hist.+0.0130
BB Upper0.9876 USD
BB Middle0.8894 USD
BB Lower0.7912 USD
BB Width22.08%
ATR (14)0.0713 USD
Vol Ratio (20d)0.87x